Characterization of gut microbiota in patients with diabetic kidney disease
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1713005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Shoujuan Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Affiliated Beijing Chaoyang Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetic Nephropathies, Bacteria. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Diabetic kidney disease (DKD) is a major complication of diabetes mellitus (DM). Although dysbiosis of the gut microbiota in DKD has been reported, the specific microbial species associated with disease progression from DM to DKD remain insufficiently defined.
Methods
We conducted shotgun metagenomic sequencing on fecal samples from 55 healthy participants, 47 patients with DM, and 38 patients with DKD. Gut microbiota diversity, composition, and functional pathways were compared across groups; correlations with glycemic and renal indices were evaluated.
Results
Overall alpha-diversity showed no significantly difference between DKD and healthy controls; however, the simpson’s index was higher in DKD than in DM (p < 0.05). There was a difference in beta-diversity between DKD and the healthy control (p = 0.002), but no significant difference was observed between the DKD and DM group. Bacteria significantly enriched in DM/DKD include Mediterraneibacter , Enterocloster , Shigella , Limosilactobacillus , and Thomasclavelia , which showed positive correlations with glycemic indicators (HbA1c, fasting blood glucose) and renal indicators (BUN, UACR). In contrast, health-enriched bacteria, Phocaeicola , Faecalibacterium , Lachnospira , Agathobacter , Odoribacter , and Paraprevotella were negatively correlated with these parameters. Functional analysis revealed that compared to the DM group, the DKD group enriched pathways related to aromatic amino acid biosynthesis (phenylalanine, tyrosine, tryptophan), biofilm formation, and lipopolysaccharide biosynthesis. Gut microbial shifts along the DM–DKD correlates with adverse glycemic and renal phenotypes, as well as functional characteristics associated with inflammation and barrier injury. These findings suggest that microbially driven metabolic and structural pathways represent potential targets for mitigating the progression of DKD.
Conclusion
This study elucidates the distinct characteristics of the gut microbiota in DKD patients and highlights potential microbial markers involved in the progression from DM to DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Affiliated Beijing Chaoyang Hospital of Capital Medical University, Beijing, China.
- Key Laboratory of Functional Dairy, Co-Constructed by Ministry of Education and Beijing Government, Department of Nutrition and Health, China Agricultural University, Beijing, China.
- Sports & Medicine Integration Research Center (SMIRC), Capital University of Physical Education and Sports, Beijing, China.
- Shunyi District Zhangxizhuang Community Healthcare Center, Beijing, China.
Zitieren
APA
Yu, S., Niu, H., Zhang, Y., Yu, L., Zhang, Q., Liu, X., Sang, Y., Wang, R., & Zhang, M. (2026). Characterization of gut microbiota in patients with diabetic kidney disease. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1713005
Vancouver
Yu S, Niu H, Zhang Y, Yu L, Zhang Q, Liu X, et al. Characterization of gut microbiota in patients with diabetic kidney disease. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1713005
BibTeX
@article{Yu2026,
author = {Yu, Shoujuan and Niu, Huimin and Zhang, Yan and Yu, Ling and Zhang, Qi and Liu, Xingchen and Sang, Yue and Wang, Ran and Zhang, Min},
title = {Characterization of gut microbiota in patients with diabetic kidney disease},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1713005}
}
EUVIMED